Skip to content

Claritev Corporation CTEV Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$978.76M+1.4%$965.41M+1.5%$951M+1.7%$935.54M+0.9%$927.45M-0.3%
$262.06M+3.4%$253.41M+5.4%$240.45M+0.5%$239.22M-0.2%$239.76M+0.1%
$716.71M+0.7%$712M+0.2%$710.55M+2.0%$696.32M+1.3%$687.68M-0.5%
73.2%-0.5pp73.8%-1.0pp74.7%+0.3pp74.4%+0.3pp74.1%-0.1pp
$228.71M+5.0%$217.85M+6.0%$205.56M+13.3%$181.39M+11.3%$163M+8.0%
$953.1M+1.8%$936.65M-2.0%$955.98M-25.8%$1.29B-29.2%$1.82B-21.5%
-$4.97M+98.6%-$353.25M+60.5%-$893.75M+35.7%
$399.93M+2.0%$392.02M+4.9%$373.87M+5.5%$354.43M+5.5%$335.81M+2.9%
-$375.93M-0.8%-$373.08M+17.5%-$452.29M+41.8%-$777.6M+40.1%-$1.3B+26.6%
-$89.41M-0.7%-$88.8M+19.7%-$110.62M+3.2%-$114.23M+6.0%-$121.45M+2.7%
-$286.52M-0.8%-$284.28M+16.8%-$341.68M+48.5%-$663.37M+43.7%-$1.18B+28.5%
-29.3%+0.2pp-29.4%+6.5pp-35.9%+35.0pp-70.9%+56.0pp-127%+49.9pp
-$17.33-0.2%-$17.30+17.3%-$20.91+48.9%-$40.93+43.9%-$72.90+28.5%
$471.78M-0.5%$474.3M+8.4%$437.51M+410%$85.83M+119%-$458.12M+52.2%
48.2%-0.9pp49.1%+3.1pp46%+36.8pp9.2%+58.6pp-49.4%+53.5pp
$25.78M-10.7%$28.88M+681%-$4.97M+98.6%-$353.25M+60.5%-$893.75M+35.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Claritev Corporation's revenue?
Claritev Corporation (CTEV) generated $978.8M in revenue over the trailing twelve months, up 5.5% year over year.
Is Claritev Corporation profitable?
Claritev Corporation is not currently profitable: it reported a net loss of $286.5M over the trailing twelve months, a -29.3% net margin.
What are Claritev Corporation's profit margins?
Gross margin is 73.2% and operating margin is -0.5%, with a -29.3% net margin.
What is Claritev Corporation's earnings per share?
Claritev Corporation's diluted EPS over the trailing twelve months is $-17.33.
Where does Claritev Corporation's income statement data come from?
Every line is extracted from Claritev Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.